SAN DIEGO, March 19, 2026 (GLOBE NEWSWIRE)-- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results